Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Moderna

Moderna Beats On Q4 Earnings, Announces $3B Buyback; Expects ~$19B In FY22 COVID-19 Vax Sales

Moderna Inc (NASDAQ:MRNA) reports a Q4 EPS of $11.29, a turnaround from an EPS loss of $(0.69) a year ago, beating the consensus estimate of $9.90. The Company clocked Q4 revenues of $7.21 billion compared to just $571 million a year ago, beating the consensus of $6.79 billion. Product sales were $6.9…

Benzinga

COVID-19 vaccine sales push Moderna to $12B profit in 2021

Moderna’s COVID-19 vaccine brought in nearly $7 billion in the final quarter of 2021, and the drugmaker says it has signed purchase agreements for another $19 billion in sales this year

The Independent UK

Moderna, Thermo Fisher Join Forces To Manufacture COVID-19 Vaccine, Other Drugs

Moderna Inc (NASDAQ: MRNA) has en

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Check Out What Whales Are Doing With MRNA

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

Benzinga

WHO works to spread COVID vaccine technology to more nations

The World Health Organization is creating a global training center to help poorer countries make vaccines, antibodies and cancer treatments using the messenger RNA technology used to make COVID-19 vaccines

The Independent UK

Thinking About Buying Stock In Coinbase, Moderna Or Sunnova Energy?

Analysts and brokerage firms often use ratings when they issue stock recommendations to stock traders. Analysts arrive at stock ratings by researching public financial statements, communicating with executives and customers and following industry trends.

Benzinga

The Moderna vaccine is now available for 6 to 11 year olds. Here's what parents need to know

Australian children aged six to 11 years old will be able to get the Moderna COVID vaccine at pharmacies, GP clinics and vaccination hubs from tomorrow.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

Moderna COVID-19 vaccine approved for six- to 11-year-old children

Children aged six to 11 years can get a Moderna COVID-19 vaccine from tomorrow, after it was given the final green light.

ABC News

Do COVID boosters cause more or fewer side effects? How quickly does protection wane? Your questions answered

The Australian Technical Advisory Group on Immunisation (ATAGI) recommends Australians aged 16 years and older have a COVID booster vaccine three months after receiving their second dose.

The Conversation

Moderna Adds Three New mRNA-Based Development Programs To Its Pipeline

Moderna Inc (NASDAQ: MRNA) said it is deve

Benzinga

How trying to copy a COVID vaccine changes the outlook for African countries

The World Health Organisation (WHO) has announced the first six African countries that will receive technology to produce messenger RNA (mRNA) vaccines. This comes off the back of the news that a South African consortium – part of the WHO’s technology transfer hub set up in 2021– had successfully replicated…

The Conversation

Six African Countries to Receive mRNA Vaccine Technology

The first African countries selected to receive the technology necessary to produce mRNA vaccines against COVID-19 are Egypt, Kenya, Nigeria, Senegal, South Africa and Tunisia, a summit meeting of European Union and African Union nations heard on Friday. The six countries have been chosen to build vaccine production factories as…

Asharq Al-Awsat

Moderna Says COVID-19 Booster To Be Ready By August, But Dicey If Omicron-Specific Needed: Reuters

Moderna Inc's (NASDAQ: MRNA) CEO, Stephane Bancel, told Reuters that an

Benzinga

This Reopening Stock Has A Better 1-Year Return Than Moderna, Pfizer, BioNTech, Novavax And Vaxart

Macy's Inc (NYSE: M) retail stores have something for everyone in the family, and over the past year, has returned unmistakable gains for bullish traders and investors.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Covid booster will be needed in autumn, says Moderna chief executive Stephane Bancel

Another Covid booster vaccine will be needed by autumn, the chief executive of Moderna has said.

The Guardian - UK

Germany and Portugal to cut restrictions – as it happened

Germany and Portugal preparing to axe most curbs as cases stabilise; Israel’s PM says ‘green pass’ system to be suspended as cases decline

ABC News

TGA approves Moderna COVID-19 vaccine for children aged six and older

The Therapeutic Goods Administration approves the Moderna vaccine for children aged six and older.

Benzinga

Moderna-Rovi Seal 10-Year Deal Extension To Make mRNA Drugs

Spain's Laboratorios Farmaceuticos Rovi SA has agreed on a 10-year extension

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa

Here's a roundup of top developments in the biotech space over the last 24 hours.

Daily Record

Covid-19: Omicron-specific vaccine trials launched in UK as volunteers needed

The trials will include 3,000 participants in 13 locations including some in Scotland.

Chronicle Live

Thousands of volunteers sought for Moderna Omicron booster vaccine study

The study will see half the volunteers receive the new Moderna Omicron variant vaccine, and the other half vaccinated with the regular Moderna jab

The Guardian - UK

Germany and Switzerland set to ease restrictions – as it happened

This blog is now closed.

Wales Online

Moderna seeks volunteers for Omicron booster vaccine study

UK volunteers needed to take part in trials

The Conversation

COVID: China is developing its own mRNA vaccine – and it's showing early promise

China, the country that first detected the novel coronavirus, remains one of the few not to have imported one of the exceptionally effective mRNA COVID vaccines developed by Pfizer and Moderna. Instead, it has so far relied on vaccines developed by two Chinese companies, Sinovac and Sinopharm. However, this may…

Benzinga

Moderna Continues To See Bearish Movement: What's Next For The COVID-19 Stock?

Moderna Inc. (NASDAQ: MRNA) shares are trading lower Monday.

1 … 30 31 32 33

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

World Health Organization

World Health Organisation

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.